ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination has been researched along with n,n-dimethyl-3,3-diphenyl-1-methylallylamine in 1 studies
| Studies (ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination) | Trials (ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination) | Recent Studies (post-2010) (ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination) | Studies (n,n-dimethyl-3,3-diphenyl-1-methylallylamine) | Trials (n,n-dimethyl-3,3-diphenyl-1-methylallylamine) | Recent Studies (post-2010) (n,n-dimethyl-3,3-diphenyl-1-methylallylamine) |
|---|---|---|---|---|---|
| 24 | 5 | 0 | 6 | 1 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kjaer, M; Nielsen, H | 1 |
1 other study(ies) available for ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination and n,n-dimethyl-3,3-diphenyl-1-methylallylamine
| Article | Year |
|---|---|
Analgesic effect and bioavailability of oral ketogan given as tablets or mixture to patients with chronic pain of malignant origin.
Topics: Administration, Oral; Adult; Aged; Allylamine; Amines; Drug Combinations; Female; Half-Life; Humans; Male; Meperidine; Middle Aged; Neoplasms; Pain, Intractable; Tablets | 1988 |